| Literature DB >> 35630779 |
Shanshan Cao1, Min Hu1, Lingli Yang1, Meiqin Li1, Zhen Shi1, Wenming Cheng1, Yazhong Zhang2, Fei Chen1, Sheng Wang3, Qunlin Zhang1.
Abstract
Ranunculus sceleratus L.(RS) has shown various pharmacological effects in traditional Chinese medicine. In our previous study, the positive therapeutic effect on α-naphthylisothiocyanate induced intrahepatic cholestasis in rats was obtained using TianJiu treatment with fresh RS. However, the chemical profile of RS has not been clearly clarified, which impedes the research progress on the therapeutic effect of RS. Herein, an ultra-high performance liquid chromatography coupled with quadrupole Orbitrap high-resolution mass spectrometry (UHPLC-Q-Orbitrap HRMS) method was developed to rapidly separate and identify multiple constituents in the 80% methanol extract of RS. A total of sixty-nine compounds (19 flavonoids, 22 organic acids, 6 coumarins, 4 lignans, 14 nitrogenous compounds, and 4 anthraquinones) were successfully characterized. A total of 12 of these compounds were unambiguously identified by standard samples. Their mass spectrometric fragmentation pathways were investigated. It is worth noting that flavonoids and lignans were identified for the first time in RS. In this study, we successfully provide the first comprehensive report on identifying major chemical constituents in RS by UHPLC-Q-Orbitrap HRMS. The obtained results enrich the RS chemical profile, paving the way for further phytochemical study, quality control, and pharmacological investigation of RS.Entities:
Keywords: Ranunculus sceleratus L. (RS); UHPLC-Q-Orbitrap HRMS; chemical constituent; fragmentation pathway
Mesh:
Substances:
Year: 2022 PMID: 35630779 PMCID: PMC9145087 DOI: 10.3390/molecules27103299
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.927
Figure 1Base peak chromatograms of RS in positive ionization mode (A) and negative ionization mode (B).
69 compounds identified in the 80% methanol extract of RS and their UHPLC-Q-Orbitrap HRMS data.
| NO. | Retention Time (min) | Ionization Mode | Molecular | Theoretical ( | Measured ( | Error (ppm) | Identified Compounds | MS/MS Fragments ( | Ref. |
|---|---|---|---|---|---|---|---|---|---|
|
| 1.37 | [M + H]+ | C4H8N2O3 | 133.0607 | 133.0604 | −2.25 | Asparagine | 133.0604, 115.0391, 97.0286, 87.0558 | [ |
|
| 1.40 | [M + H]+ | C5H9NO4 | 148.0604 | 148.0598 | −4.05 | Glutamic acid | 148.0598, 102.0550, 84.0447 | [ |
|
| 1.40 | [M + H]+ | C4H9NO3 | 120.0655 | 120.0655 | 0.00 | Threonine | 120.0655, 102.0553, 74.0607, 56.0503 | [ |
|
| 1.40 | [M + H]+ | C5H7NO3 | 130.0498 | 130.0499 | 0.77 | Pyroglutamic acid | 130.0499, 102.0551, 84.0449 | [ |
| 1.40 | [M − H]− | C5H7NO3 | 128.0342 | 128.0340 | −1.56 | Pyroglutamic acid | 128.0339, 85.0279, 68.1163 | ||
|
| 1.42 | [M − H]− | C6H12O7 | 195.0499 | 195.0501 | 1.03 | Gluconic acid | 195.0501, 129.018, 75.0072 | [ |
|
| 1.47 | [M + H]+ | C5H9NO2 | 116.0706 | 116.0704 | −1.72 | Proline | 116.0704, 70.0656 | [ |
|
| 1.51 | [M + H]+ | C4H5N3O | 112.0505 | 112.0507 | 1.78 | Cytosine | 112.0507, 95.0244, 69.0455 | [ |
|
| 1.57 | [M − H]− | C4H6O5 | 133.0131 | 133.0129 | −1.50 | Malic acid | 133.0129, 115.0023, 71.0124 | [ |
|
| 1.91 | [M + H]+ | C5H5N5O | 152.0567 | 152.0565 | −1.32 | Guanine | 152.0565, 135.0300, 110.0351 | [ |
|
| 1.91 | [M + H]+ | C6H5NO2 | 124.0393 | 124.0394 | 0.81 | Nicotinic acid | 124.0394, 106.0291, 96.0448, 80.0501 | [ |
|
| 1.99 | [M + H]+ | C6H6N2O | 123.0553 | 123.0554 | 0.81 | Nicotinamide | 123.0554, 80.0501 | [ |
|
| 2.13 | [M − H]− | C6H6O6 | 173.0080 | 173.0082 | 1.16 | Aconitic acid | 173.0082, 129.0179, 111.0072, 85.0279 | [ |
|
| 2.17 | [M − H]− | C5H4O3 | 111.0076 | 111.0073 | −2.70 | Furoic acid | 111.0073, 83.0122, 67.0174 | [ |
|
| 2.24 | [M − H]− | C6H8O7 | 191.0186 | 191.0187 | 0.52 | Citric acid | 191.0187, 111.0073, 87.0072 | [ |
|
| 2.62 | [M + H]+ | C4H4N2O2 | 113.0345 | 113.0347 | 1.77 | Uracil | 113.0347, 96.0084, 70.0294 | [ |
|
| 2.64 | [M − H]− | C4H6O4 | 117.0182 | 117.0179 | −2.56 | Succinic acid | 117.0179, 99.0073, 73.0280 | [ |
|
| 5.05 | [M + H]+ | C9H11NO2 | 166.0862 | 166.0861 | −0.60 | Phenylalanine | 166.0861, 120.0809, 103.0545 | [ |
|
| 7.09 | [M − H]− | C13H16O9 | 315.0711 | 315.0722 | 3.49 | Protocatechuic acid-O-glucose | 315.0722, 153.0545, 109.0280 | [ |
|
| 7.28 | [M − H]− | C14H18O9 | 329.0867 | 329.0858 | −2.73 | Vanillic acid-O-glucopyranoside | 329.0858, 167.033, 123.0437 | [ |
|
| 7.28 | [M − H]− | C14H20O8 | 315.1074 | 315.1092 | 5.71 | Hydroxytyrosol-1-glucopyranoside | 315.1092, 153.0545 | [ |
|
| 7.37 | [M−H]− | C7H6O4 | 153.0182 | 153.0181 | −0.65 | Protocatechuic acid | 153.0181, 123.0437, 109.0280, 91.0176 | Standard |
|
| 7.61 | [M−H]− | C15H18O9 | 341.0867 | 341.0873 | 1.76 | Caffeic acid-O-glucopyranoside | 341.0873, 179.0339, 135.0439 | [ |
|
| 7.61 | [M + H]+ | C11H12N2O2 | 205.0972 | 205.0970 | −0.98 | Tryptophan | 205.0970, 188.0703, 159.0914, 146.0598 | [ |
| 7.61 | [M − H]− | C11H12N2O2 | 203.0815 | 203.0818 | 1.48 | Tryptophan | 203.0818, 186.0551, 159.091, 142.0649 | ||
|
| 7.65 | [M − H]− | C15H16O9 | 339.0711 | 339.0718 | 2.06 | Esculin | 339.0718,177.0183 | [ |
|
| 7.67 | [M − H]− | C13H16O8 | 299.0761 | 299.0777 | 5.35 | Salicylic acid-O-glucopyranoside | 299.0777, 137.0231, 93.0331 | [ |
|
| 7.78 | [M − H]− | C27H30O16 | 609.1450 | 609.1464 | 2.30 | Kaempferol-3,7-di-O-glucoside | 609.1464, 447.0930, 285.0402, 255.0295, 151.0023 | [ |
|
| 7.82 | [M − H]− | C7H6O3 | 137.0233 | 137.0231 | −1.46 | Protocatechualdehyde | 137.0231, 109.0279, 108.0201, 93.0330 | [ |
|
| 7.89 | [M − H]− | C16H18O9 | 353.0867 | 353.0865 | −0.57 | Scopolin | 353.0865, 191.0553, 179.0341, 173.0450, 135.0439 | [ |
|
| 7.91 | [M − H]− | C15H18O8 | 325.0918 | 325.0928 | 3.08 | 325.0928, 163.0388, 119.0487, | [ | |
|
| 8.12 | [M − H]− | C27H30O16 | 609.1450 | 609.1453 | 0.49 | Kaempferol-O-sophoroside | 609.1453, 429.0818, 284.0323, 255.0295, 227.0343 | [ |
|
| 8.16 | [M − H]− | C9H6O4 | 177.0182 | 177.0182 | 0.00 | Aesculetin | 177.0182, 149.0231, 133.0280, 121.0280 | Standard |
|
| 8.21 | [M − H]− | C9H8O4 | 179.0339 | 179.0342 | 1.68 | Caffeic acid | 179.0342, 135.0437, 90.9966 | Standard |
|
| 8.25 | [M − H]− | C26H28O16 | 595.1294 | 595.1301 | 1.18 | Quercetin-O-(pentosyl)hexoside isomer | 595.1301, 300.0274, 271.0248, 255.0294, 151.0022, 135.0433 | [ |
|
| 8.51 | [M − H]− | C11H13NO3 | 206.0811 | 206.0813 | 0.97 | 206.0813, 164.0705, 147.0438, 118.9914, 91.0536 | [ | |
|
| 8.53 | [M − H]− | C21H20O11 | 447.0922 | 447.0929 | 1.57 | Isoorientin | 447.0929, 429.0821, 357.0613, 327.0508, 285.0420, 133.0281 | [ |
|
| 8.55 | [M − H]− | C8H14O4 | 173.0808 | 173.0808 | 0.00 | Suberic acid | 173.0808, 129.0906, 111.0800 | [ |
|
| 8.59 | [M + H]+ | C10H8O4 | 193.0495 | 193.0490 | −2.95 | Isoscopoletin | 193.0490, 178.0255, 133.0280 | Standard |
|
| 8.60 | [M − H]− | C26H32O12 | 535.1810 | 535.1818 | 1.49 | 1-Hydroxylpinoresinol 4’-O-glucopyranoside | 535.1818, 373.1284, 343.1182 | [ |
|
| 8.62 | [M + H]+ | C21H20O12 | 465.1027 | 465.1024 | −0.65 | Hyperoside | 465.1024, 303.0494, 257.0439, 229.0493, 153.0181 | [ |
| 8.62 | [M − H]− | C21H20O12 | 463.0871 | 463.0882 | 2.38 | Hyperoside | 463.0882, 301.0350, 271.0244, 178.9974, 151.0023 | [ | |
|
| 8.77 | [M − H]− | C9H8O3 | 163.0389 | 163.0390 | 0.61 | Coumaric acid | 163.0390, 119.0488 | [ |
|
| 8.88 | [M + H]+ | C16H12O7 | 317.0656 | 317.0649 | −2.21 | Isorhamnetin | 317.0649, 302.0416, 285.0388, 274.0467, 153.0180 | [ |
|
| 8.91 | [M + H]+ | C15H10O6 | 287.0550 | 287.0545 | −1.74 | Kaempferol | 287.0545, 269.0437, 231.0651, 213.0541, 153.0180, 121.0285 | [ |
|
| 8.92 | [M − H]− | C22H22O12 | 477.1028 | 477.1034 | 1.26 | Isorhamnetin-3-O-glucoside isomer | 477.1034, 314.0430, 285.0402, 271.0247, 243.0295 | [ |
|
| 8.94 | [M + H]+ | C10H8O4 | 193.0495 | 193.0493 | −1.04 | Scopoletin | 193.0493, 178.0258, 175.1479, 150.0309, 133.0283, 109.0857 | Standard |
| 8.94 | [M − H]− | C10H8O4 | 191.0339 | 191.0340 | 0.52 | Scopoletin | 191.0340, 176.0105, 146.973,111.0074, 102.9474 | ||
|
| 8.96 | [M − H]− | C21H20O11 | 447.0933 | 447.0930 | −0.67 | Luteoloside | 447.0930, 285.0420, 255.0296, 241.0500, 217.05.01, 227.0343, 199.0395, 151.0023 | [ |
|
| 8.98 | [M − H]− | C10H10O4 | 193.0495 | 193.0495 | 0.00 | Ferulic acid | 193.0495, 178.0261, 149.0595,134.0360, 121.0282 | Standard |
|
| 9.03 | [M + H]+ | C21H18O11 | 447.0922 | 447.0924 | 0.45 | Apigenin-7-O-glucuronide | 447.0924, 271.0595, 231.1145, 199.2475, 153.0180, 119.0490 | [ |
| 9.03 | [M − H]− | C21H18O11 | 445.0765 | 445.0752 | −2.92 | Apigenin-7-O-glucuronide | 445.0752, 269.0452, 175.0233, 113.0229 | ||
|
| 9.06 | [M − H]− | C21H18O12 | 461.0714 | 461.0727 | 2.82 | Luteolin-7-O-glucuronide | 461.0727, 285.0402, 151.0022, 133.0279 | [ |
|
| 9.10 | [M − H]− | C26H32O11 | 519.1861 | 519.1873 | 2.31 | Matairesinoside | 519.1972, 357.1340, 342.1098, 313.1464, 221.0804, 161.0595 | [ |
|
| 9.22 | [M − H]− | C9H16O4 | 187.0964 | 187.0966 | 1.07 | Azelaic acid | 187.0966, 125.0958, 97.0644 | [ |
|
| 9.31 | [M − H]− | C9H10O3 | 165.0546 | 165.0545 | −0.61 | 165.0545, 147.0439, 136.9310, 119.0488, 72.9916 | [ | |
|
| 9.33 | [M − H]− | C20H22O7 | 373.1282 | 373.1289 | 1.88 | 1-Hydroxylpinoresinol | 373.1289, 343.1176, 313.1081, 298.0844, 147.0439, 123.0074, 109.0277 | [ |
|
| 9.68 | [M − H]− | C7H6O3 | 137.0233 | 137.0232 | −0.73 | Salicylic acid | 137.0232, 93.0331 | Standard |
|
| 9.82 | [M + H]+ | C11H10O4 | 207.0652 | 207.0649 | −1.45 | Scoparone | 207.0649, 191.0337, 163.0388, 151.0752, 121.0648, 105.0703 | Standard |
|
| 10.28 | [M + H]+ | C15H10O6 | 287.0550 | 287.0545 | −1.74 | Luteolin | 287.0545, 153.0180, 131.0439 | Standard |
| 10.28 | [M − H]− | C15H10O6 | 285.0393 | 285.0403 | 3.51 | Luteolin | 285.0403, 175.0387, 133.0281,121.0279, 107.0125, 83.0124 | ||
|
| 10.32 | [M − H]− | C15H10O7 | 301.0343 | 301.0355 | 3.99 | Quercetin | 301.0355, 229.0504, 201.0565, 178.9975, 151.0024, 121.0281 | Standard |
|
| 10.83 | [M − H]− | C20H22O6 | 357.1332 | 357.1341 | 2.52 | Matairesinol | 357.1341, 342.1097, 313.0370, 283.0078, | [ |
|
| 11.06 | [M + H]+ | C15H10O5 | 271.0601 | 271.0595 | −2.21 | Apigenin | 271.0595, 153.0181, 119.0492 | [ |
| 11.06 | [M − H]− | C15H10O5 | 269.0444 | 269.0453 | 3.35 | Apigenin | 269.0453, 251.0590, 227.0341, 181.0644, 151.0025, 117.0332 | ||
|
| 11.16 | [M − H]− | C16H12O6 | 299.0550 | 299.0560 | 3.34 | Chrysoeriol | 299.0560, 284.0326, 256.0372, 255.0293, | [ |
|
| 11.19 | [M − H]− | C15H10O6 | 285.0394 | 285.0403 | 3.16 | 7-Hydroxy-emodin | 285.0403, 257.0449, 211.0380 | [ |
|
| 11.41 | [M − H]− | C16H12O6 | 299.0550 | 299.0561 | 3.68 | Diosmetin | 299.0561, 284.0325, 256.0378, 255.0296, 227.0344 | [ |
|
| 11.51 | [M − H]− | C16H12O7 | 315.0499 | 315.0508 | 2.86 | Rhamnetin | 315.0508, 300.0271, 151.0024,107.0123 | [ |
|
| 11.67 | [M − H]− | C16H12O5 | 283.0601 | 283.0611 | 3.53 | 1-O-Methyl-emodin | 283.0611, 268.0376, 239.0346, 211.0395 | [ |
|
| 12.75 | [M − H]− | C15H12O4 | 255.0651 | 255.0659 | 3.14 | Pinocembrin | 255.0659, 213.0549, 171.0441, 151.0024 | [ |
|
| 12.95 | [M + H]+ | C17H14O6 | 315.0863 | 315.0857 | −1.90 | 7,3′-Dihydroxy-8,4′-dimethoxyisoflavone/isomer | 315.0857, 300.0623 | [ |
|
| 13.21 | [M − H]− | C16H12O5 | 283.0601 | 283.0610 | 3.18 | Physcion | 283.0610, 268.0377, 239.0346, 211.0393 | [ |
|
| 13.77 | [M + H]+ | C18H39NO3 | 318.3002 | 318.2996 | −1.89 | 2-Amino-1,3,4-octadecanetriol | 318.2996, 300.2891, 282.2787, 264.2681, 60.0452 | [ |
|
| 14.02 | [M − H]− | C15H10O5 | 269.0444 | 269.0455 | 4.09 | Emodin | 269.0455, 241.0504, 225.0552, 210.0320 | Standard |
|
| 17.25 | [M − H]− | C30H48O3 | 455.3531 | 455.3528 | −0.66 | Oleanic acid | 455.3528, 240.9500, 206.1664, 82.4031 | Standard |
Figure 2Characteristic of MS/MS spectra and possible fragmentation pathways of hyperoside (A) and apigenin-7-O-glucuronide (B).
Figure 3Characteristic of MS/MS spectra and possible fragmentation pathways of protocatechuic acid (A) and salicylic acid-O-glucopyranoside (B).
Figure 4Characteristic of MS/MS spectra and possible fragmentation pathways of scopoletin (A) and hydroxylpinoresinol 4′-O-glucopyranoside (B).
Figure 5Characteristic of MS/MS spectra and possible fragmentation pathways of proline.
Figure 6Characteristic of MS/MS spectra and possible fragmentation pathways of emodin.